AAAAAA
Results:
1-12
|
Results: 12
Authors:
OR R
ACKERSTEIN A
NAGLER A
AMAR A
NAPARSTEK E
VARADI G
KAPELUSHNIK J
SAMUEL S
PUGATSCH T
BRAUTBAR C
SLAVIN S
Citation: R. Or et al., ALLOGENEIC CELL-MEDIATED AND CYTOKINE-ACTIVATED IMMUNOTHERAPY FOR MALIGNANT-LYMPHOMA AT THE STAGE OF MINIMAL RESIDUAL DISEASE AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION, Journal of immunotherapy, 21(6), 1998, pp. 447-453
Authors:
AKER M
KAPELUSHNIK J
PUGATSCH T
NAPARSTEK E
BENNERIA S
YEHUDA O
AMAR A
NAGLER A
SLAVIN S
OR R
Citation: M. Aker et al., DONOR LYMPHOCYTE INFUSIONS TO DISPLACE RESIDUAL HOST HEMATOPOIETIC-CELLS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR BETA-THALASSEMIA MAJOR, Journal of pediatric hematology/oncology, 20(2), 1998, pp. 145-148
Authors:
KAPELUSHNIK J
AKER M
PUGATSCH T
SAMUEL S
SLAVIN S
Citation: J. Kapelushnik et al., BONE-MARROW TRANSPLANTATION FROM A CADAVERIC DONOR, Bone marrow transplantation, 21(8), 1998, pp. 857-858
Authors:
MORECKI S
NAGLER A
ZAKAYRONES Z
SCHLESINGER M
LUBINASALOMON A
PUGATSCH T
MOSHEL Y
SLAVIN S
Citation: S. Morecki et al., TUMORIGENICITY AND IMMUNOGENICITY IN A MURINE MODEL OF B-CELL LEUKEMIA LYMPHOMA (BCL1)/, Leukemia research, 22(9), 1998, pp. 831-835
Authors:
PUGATSCH T
OR R
SLAVIN S
KAPELUSHNIK J
Citation: T. Pugatsch et al., AMELOGENIN AS MARKER FOR BONE-MARROW ENGRAFTMENT - A SHORT-TERM STUDY, Journal of tumor marker oncology, 12(4), 1997, pp. 47-51
Authors:
MORECKI S
MOSHEL Y
GELFEND Y
PUGATSCH T
SLAVIN S
Citation: S. Morecki et al., INDUCTION OF GRAFT VS TUMOR EFFECT IN A MURINE MODEL OF MAMMARY ADENOCARCINOMA, International journal of cancer, 71(1), 1997, pp. 59-63
Authors:
PUGATSCH T
OPPENHEIM A
SLAVIN S
Citation: T. Pugatsch et al., IMPROVED SINGLE-STEP PCR ASSAY FOR SEX IDENTIFICATION POST-ALLOGENEICSEX-MISMATCHED BMT, Bone marrow transplantation, 17(2), 1996, pp. 273-275
Authors:
MORECKI S
PUGATSCH T
LEVI S
MOSHEL Y
SLAVIN S
Citation: S. Morecki et al., TUMOR-CELL VACCINATION INDUCES TUMOR DORMANCY IN A MURINE MODEL OF B-CELL LEUKEMIA LYMPHOMA (BCL(1))/, International journal of cancer, 65(2), 1996, pp. 204-208
Authors:
KIRSCHBAUM M
OR R
NAGLER A
NAPARSTEK E
KAPELUSHNIK J
VARADI G
BENYOSEF R
SAMUEL S
AMAR A
PUGATSCH T
SLAVIN S
Citation: M. Kirschbaum et al., CONDITIONING WITH NON-MYELOABLATIVE IMMUNOSUPPRESSIVE THERAPY ALONE IS ADEQUATE TO INDUCE CHIMERISM IN ALLOGENEIC TRANSPLANT FOR HEMATOLOGIC MALIGNANCIES, Blood, 88(10), 1996, pp. 3827-3827
Authors:
PUGATSCH T
NAGLER A
NAPARSTEK E
KAPELUSHNIK J
ACKER M
SLAVIN S
OR R
Citation: T. Pugatsch et al., LONG-TERM STUDY OF CHIMERISM FOLLOWING ALLOGENEIC SEX-MISMATCHED BMT DETECTED BY AMG-PCR, Blood, 86(10), 1995, pp. 412-412
Authors:
ACKERSTEIN A
VOURKAKARUSSIS U
PUGATSCH T
SLAVIN S
Citation: A. Ackerstein et al., ADOPTIVE TRANSFER OF ALLOGENEIC RIL-2 ACTIVATED DONOR LYMPHOCYTES (ADL) AND RECOMBINANT INTERLEUKIN-2 (RIL-2) - AN APPROACH FOR CELL THERAPY IN RELAPSING PATIENTS FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 3886-3886
Authors:
PUGATSCH T
WEISS L
SLAVIN S
Citation: T. Pugatsch et al., MINIMAL RESIDUAL DISEASE IN MURINE B-CELL LEUKEMIA (BCL1) DETECTED BYPCR, Leukemia research, 17(11), 1993, pp. 999-1002
Risultati:
1-12
|